Increasing antibiotic resistance of bacteria is one of the biggest future challenges of medicine. Nature may offer us new solutions in the form of oligomeric ellagitannins.
A joint project of HUS Helsinki University Hospital, VTT Technical Research Centre of Finland, University of Turku, and Hospital Universitario Principe de Astúrias and research institute Fundación Jiménez Díaz from Spain investigated the efficacy of compounds fractionated from berries against microbes that cause wound infections. The study found that ellagitannins, compounds fractionated from cloudberry seeds, have a significant antimicrobial activity against MRSA, a hospital bacterium.
Read the news from the University of Turku, and the original scientific publication from Antibiotics.